Blephamide
NDC Package 11980-022-05
Package Information
Blephamide is a medication used to prevent or treat eye infections and to treat swelling in the eye. Marketed by Allergan, Inc., this product is identified by NDC 11980-022 and is authorized under FDA application NDA012813.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11980 - Allergan, Inc.
- 11980-022 - Blephamide
- 11980-022-05 - 1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER
- 11980-022 - Blephamide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (11980-022). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11980-022-05 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 5 ml in 1 bottle, dropper of Blephamide, labeled by Allergan, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Allergan, Inc. on October 01, 1961. The current certification is valid through May 31, 2022.
What are the primary indications for this medication?
This medication is used to prevent or treat eye infections and to treat swelling in the eye. This product contains an antibiotic (sulfacetamide) that stops the growth of bacteria and a corticosteroid (prednisolone) that reduces inflammation. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.
How is this Allergan, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11980002205. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.